Caffeic Acid Protects Against Ulcerative Colitis via Inhibiting Mitochondrial Apoptosis and Immune Overactivation in Drosophila
Drug Design, Development and Therapy · 2025-03 · Volume 19 · 2157-2172
DOI: 10.2147/dddt.s499284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025-03. Verfasst von Minghui Xiu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health, Gansu University of Chinese Medicine, Lanzhou City, Gansu Province, People's Republic of China. Hauptthemen laut MEDLINE: Caffeic Acids, Apoptosis, Colitis, Ulcerative, Mitochondria. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Ulcerative colitis (UC) is a chronic intestinal inflammation that is prone to relapse and is difficult to fully recover; therefore, there is a need for safer alternative treatments. Caffeic acid (CA) is a natural polyphenolic compound that has antioxidant and anti-inflammatory properties. However, the beneficial effects and mechanisms of action of CA in UC remain unclear.
Purpose
This study evaluated the protective effect of CA against dextran sulfate sodium (DSS)-induced intestinal injury in Drosophila melanogaster model.
Results
Oral administration of CA significantly reduced body damage in UC flies, improved their survival rate, restored damaged digestion, and improved locomotion. CA supplementation significantly alleviated intestinal damage in UC flies by restoring excretion balance, repairing intestinal atrophy, improving acid-base balance imbalance, inhibiting intestinal structural destruction, inhibiting intestinal epithelial cell death and intestinal stem cell (ISC) excessive proliferation, and reducing the number of harmful bacteria. Mechanistic studies found that CA significantly reduced the expression of Toll and Imd pathway genes (including Myd88, Dif, PGRP-LC, Imd, Rel, and Dpt), reduced ROS levels and the expression of apoptosis-related genes (Debcl, Cyt-c-p, DrlCE, Dronc, and Dark), and increased ATP and MFN2 levels.
Conclusion
CA alleviated intestinal damage mainly by inhibiting the Toll and Imd signaling pathways and inhibiting apoptosis mediated by mitochondrial damage. These findings suggest that CA holds promise as a potential therapeutic for UC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Public Health, Gansu University of Chinese Medicine, Lanzhou City, Gansu Province, People's Republic of China.
- Key Laboratory of Dunhuang Medicine, Ministry of Education, Lanzhou City, Gansu Province, People's Republic of China.
- Provincial-Level Key Laboratory for Molecular Medicine of Major Diseases and the Prevention and Treatment with Traditional Chinese Medicine Research in Gansu Colleges and University, Gansu University of Chinese Medicine…
- Tibetan Medical College, Qinghai University, Xining City, Qinghai Province, People's Republic of China.
- Research and Experimental Center, Gansu University of Chinese Medicine, Lanzhou City, Gansu Province, People's Republic of China.
ORCID-Profile: Yongqi Liu, Jianzheng He
Zitieren
APA
Xiu, M., Li, B., He, L., Shi, Y., Zhang, Y., Zhou, S., Liu, Y., Wang, N., & He, J. (2025). Caffeic Acid Protects Against Ulcerative Colitis via Inhibiting Mitochondrial Apoptosis and Immune Overactivation in Drosophila. Drug Design, Development and Therapy, Volume 19, 2157-2172. https://doi.org/10.2147/dddt.s499284
Vancouver
Xiu M, Li B, He L, Shi Y, Zhang Y, Zhou S, et al. Caffeic Acid Protects Against Ulcerative Colitis via Inhibiting Mitochondrial Apoptosis and Immune Overactivation in Drosophila. Drug Design, Development and Therapy. 2025;Volume 19:2157-2172. doi:10.2147/dddt.s499284
BibTeX
@article{Xiu2025,
author = {Xiu, Minghui and Li, Botong and He, Li and Shi, Yan and Zhang, Yongxuan and Zhou, Shihong and Liu, Yongqi and Wang, Ningbo and He, Jianzheng},
title = {Caffeic Acid Protects Against Ulcerative Colitis via Inhibiting Mitochondrial Apoptosis and Immune Overactivation in Drosophila},
journal = {Drug Design, Development and Therapy},
year = {2025},
volume = {Volume 19},
pages = {2157--2172},
doi = {10.2147/dddt.s499284}
}
EUVIMED